![Polio Vaccine - WordPress.com](http://s1.studyres.com/store/data/001381442_1-767f425655b1b911e160089bac6c29cf-300x300.png)
the last epidemic - Wall Street Journal
... the danger posed by these isolated smallpox cases, one point remains clear: There was precious little panic. Outside schools, fire stations and hospitals, the vaccination lines snaked for blocks. People didn’t worry about the vaccine’s safety; they feared that there might not be enough vaccine to go ...
... the danger posed by these isolated smallpox cases, one point remains clear: There was precious little panic. Outside schools, fire stations and hospitals, the vaccination lines snaked for blocks. People didn’t worry about the vaccine’s safety; they feared that there might not be enough vaccine to go ...
Polio - Interhealth
... from polio and the possibility that polio virus will re-emerge in countries previously declared polio-free. The disease can be introduced to polio-free countries by infected travellers. It is therefore important that adults and children complete their full course of polio vaccinations as part of the ...
... from polio and the possibility that polio virus will re-emerge in countries previously declared polio-free. The disease can be introduced to polio-free countries by infected travellers. It is therefore important that adults and children complete their full course of polio vaccinations as part of the ...
The Virus
... either side of the face, below the ears. The main symptoms are severe swelling and soreness of the cheeks and ...
... either side of the face, below the ears. The main symptoms are severe swelling and soreness of the cheeks and ...
Containment overview
... Polioviruses: human enteroviruses that exist as 3 well defined serotypes, which infect cells via a specific receptor (PVR:CD155) Wild polioviruses: field isolates and reference strains derived from polioviruses known or believed to have circulated persistently in the community Oral polio vaccine str ...
... Polioviruses: human enteroviruses that exist as 3 well defined serotypes, which infect cells via a specific receptor (PVR:CD155) Wild polioviruses: field isolates and reference strains derived from polioviruses known or believed to have circulated persistently in the community Oral polio vaccine str ...
What causes polio? What are the signs and symptoms of polio? How
... mild and do not have any symptoms. Otherwise, between three days and three weeks after the infection a child might get a slight fever, sore throat and experience vomiting. This may pass within a few days but sometimes it can be followed by serious illness. With serious cases of polio, the brain and ...
... mild and do not have any symptoms. Otherwise, between three days and three weeks after the infection a child might get a slight fever, sore throat and experience vomiting. This may pass within a few days but sometimes it can be followed by serious illness. With serious cases of polio, the brain and ...
Polio CLINICAL CASE DEFINITION
... endemic in just four countries (Afghanistan, Nigeria, Pakistan, and India), although there have been numerous instances of spread to polio-nonendemic countries, mainly on the African continent. Rare instances of vaccine-associated paralytic poliomyelitis can occur in countries using live-attenuated ...
... endemic in just four countries (Afghanistan, Nigeria, Pakistan, and India), although there have been numerous instances of spread to polio-nonendemic countries, mainly on the African continent. Rare instances of vaccine-associated paralytic poliomyelitis can occur in countries using live-attenuated ...
Vaccine-Derived Poliovirus - Global Polio Eradication Initiative
... forms of all three strains of polio, including type 2. Wild poliovirus type 2 was eradicated in 1999. The weakened type 2 strain in trivalent OPV is no longer needed to protect children from wild polio, but causes nearly 90% of all cVDPV. In April 2016, all countries switched to bivalent OPV, which ...
... forms of all three strains of polio, including type 2. Wild poliovirus type 2 was eradicated in 1999. The weakened type 2 strain in trivalent OPV is no longer needed to protect children from wild polio, but causes nearly 90% of all cVDPV. In April 2016, all countries switched to bivalent OPV, which ...
Vaccines - Margie Patlak
... doses), or brain damage (1 in every 330,000 doses). Although these complications have made the DTP vaccine quite controversial, itt not clear whether these problems stem from the shot itself or are coincidental to its administration. As frightening as these rare side effects are, the American Counci ...
... doses), or brain damage (1 in every 330,000 doses). Although these complications have made the DTP vaccine quite controversial, itt not clear whether these problems stem from the shot itself or are coincidental to its administration. As frightening as these rare side effects are, the American Counci ...
Appendix B: Provincial Case Definitions for Reportable Diseases
... from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/35s2/Polio-eng.php Public Health Ontario [Internet]. Toronto, ON: Ontario Agency for Health Protection and Promotion; c2014. Laboratory services: test directory index; 2014 [cited Jun 23 2014]. Available from: ...
... from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/35s2/Polio-eng.php Public Health Ontario [Internet]. Toronto, ON: Ontario Agency for Health Protection and Promotion; c2014. Laboratory services: test directory index; 2014 [cited Jun 23 2014]. Available from: ...
Fact Sheet: Vaccine-Derived Poliovirus
... does not contain the type 2 component will reduce the risk of cVDPV. Begin introduction of inactivated polio vaccine (IPV), which cannot cause cVDPV and boosts immunity when administered in combination with OPV. All countries are on track to introduce IPV by the end of 2015. ...
... does not contain the type 2 component will reduce the risk of cVDPV. Begin introduction of inactivated polio vaccine (IPV), which cannot cause cVDPV and boosts immunity when administered in combination with OPV. All countries are on track to introduce IPV by the end of 2015. ...
MEDICAL INNOVATION: POLIO VACCINE (PHARMACEUTICAL
... BIOLOGICALS) Physician: Dr. Jonas Salk, Dr. Albert Sabin Academic: University of Pittsburgh, University of Cincinnati Organization: National Foundation for Infantile Paralysis (NFIP) – later known as the March of Dimes, World Health Organization ...
... BIOLOGICALS) Physician: Dr. Jonas Salk, Dr. Albert Sabin Academic: University of Pittsburgh, University of Cincinnati Organization: National Foundation for Infantile Paralysis (NFIP) – later known as the March of Dimes, World Health Organization ...
PICORNAVIRIDAE
... 35 days though in most cases it is between 7-14 days. Most infections are asymptomatic or inapparent. The following clinical manifestations of disease can be divided into three categories: abortive poliomyelitis, aseptic meningitis, and ...
... 35 days though in most cases it is between 7-14 days. Most infections are asymptomatic or inapparent. The following clinical manifestations of disease can be divided into three categories: abortive poliomyelitis, aseptic meningitis, and ...
Vaccination against diphtheria, tetanus, pertussis (whooping cough
... Tetanus is caused by a bacteria present in soil. The bacteria produce toxins that attack the nervous system causing muscle stiffness and painful cramps. Infection can occur when the bacteria enter open wounds and it is not contagious. The disease has a high death rate.. Tetanus is less common in Sca ...
... Tetanus is caused by a bacteria present in soil. The bacteria produce toxins that attack the nervous system causing muscle stiffness and painful cramps. Infection can occur when the bacteria enter open wounds and it is not contagious. The disease has a high death rate.. Tetanus is less common in Sca ...
imovax polio
... effects have been reported. In pregnant women exposed to a polio risk, vaccination should only be performed in cases of necessity. Breast feeding is not a contraindication. Mode of Administration and Dosage To be injected by subcutaneous or intramuscular route. It is recommended to inject this vacci ...
... effects have been reported. In pregnant women exposed to a polio risk, vaccination should only be performed in cases of necessity. Breast feeding is not a contraindication. Mode of Administration and Dosage To be injected by subcutaneous or intramuscular route. It is recommended to inject this vacci ...
Poliomyelitis
... Poliomyelitis is a viral infection caused by any of three serotypes of human poliovirus and is most often recognized by the acute onset of flaccid paralysis. It affects primarily children under the age of 5 years. Transmission is primarily person-to-person spread, principally through the fecal-oral ...
... Poliomyelitis is a viral infection caused by any of three serotypes of human poliovirus and is most often recognized by the acute onset of flaccid paralysis. It affects primarily children under the age of 5 years. Transmission is primarily person-to-person spread, principally through the fecal-oral ...
Polio Eradication
... *Non-polio acute flaccid paralysis (AFP) detection is a sensitive indicator of the precision of a polio surveillance system. Given the normal frequency of non-polio AFP in a population, an effective surveillance system should diagnose at least one case per 100,000 population under the age of 15. The ...
... *Non-polio acute flaccid paralysis (AFP) detection is a sensitive indicator of the precision of a polio surveillance system. Given the normal frequency of non-polio AFP in a population, an effective surveillance system should diagnose at least one case per 100,000 population under the age of 15. The ...
Patterns of polio infection
... • INFECTIOUS MONONUCLEOSIS is the best known clinical syndrome caused mostly by Epstein-Barr virus (EBV).it also called glandular fever. The virus is related to herpes group; DNA virus. It causes 90% of infectious mononucleosis syndrome. • Other 10% caused by CMV and Toxoplasmosis, even adenovirus. ...
... • INFECTIOUS MONONUCLEOSIS is the best known clinical syndrome caused mostly by Epstein-Barr virus (EBV).it also called glandular fever. The virus is related to herpes group; DNA virus. It causes 90% of infectious mononucleosis syndrome. • Other 10% caused by CMV and Toxoplasmosis, even adenovirus. ...
Polio_virus
... • Group: IV; Family: Picornaviridae; Genus: Enterovirus; Species: Poliovirus • There are several types of polio: nonparalytic polio & paralytic polio. Paralytic polio can be divided into: Spinal polio, bulbar polio, and bulbospinal polio. • Post-polio syndrome may also occur in which symptoms rangin ...
... • Group: IV; Family: Picornaviridae; Genus: Enterovirus; Species: Poliovirus • There are several types of polio: nonparalytic polio & paralytic polio. Paralytic polio can be divided into: Spinal polio, bulbar polio, and bulbospinal polio. • Post-polio syndrome may also occur in which symptoms rangin ...
Childhood Infectious Diseases
... outbreaks increased. The U.S. is seeing a decline in TB cases. Once symptoms show up, rabies is almost 100% fatal. Death is slow and painful. ...
... outbreaks increased. The U.S. is seeing a decline in TB cases. Once symptoms show up, rabies is almost 100% fatal. Death is slow and painful. ...
POLIOMYELITIS - Department of Community Medicine ACME
... • Predominant sign – Asymmetrical flaccid paralysis (AFP) • If fever at time of onset of paralysis – polio suspected • Other symptoms - malaise, anorexia, nausea, vomiting, abdominal pain, sore throat, head ache and constipation ...
... • Predominant sign – Asymmetrical flaccid paralysis (AFP) • If fever at time of onset of paralysis – polio suspected • Other symptoms - malaise, anorexia, nausea, vomiting, abdominal pain, sore throat, head ache and constipation ...
Poliovirus
... The mouth is the portal of entry of the virus and primary multiplication takes place in the oropharynx or intestine. The virus is regularly present in the throat and in the stools before the onset of illness. ...
... The mouth is the portal of entry of the virus and primary multiplication takes place in the oropharynx or intestine. The virus is regularly present in the throat and in the stools before the onset of illness. ...
Poliomyelitis
![](https://commons.wikimedia.org/wiki/Special:FilePath/Polio_lores134.jpg?width=300)
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.